Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
7 studies found for:    21374666 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Not yet recruiting A New Track Ablation Device for Liver Biopsy: A Feasibility Study
Condition: Liver Neoplasms
Intervention: Device: Biopsy Track Ablator (STARmed, Goyang, Korea)
2 Active, not recruiting RFA+Highly-purified CTL vs. RFA Alone for Recurrent HCC
Condition: Hepatocellular Carcinoma
Interventions: Procedure: RFA;   Procedure: RFA+highly-purified CTL
3 Not yet recruiting Prophylactic Treatment of Hepatic Dysplastic Nodules in HBsAg Positive Patients
Conditions: Dysplastic Nodule of Liver;   Chronic Hepatitis B
Intervention: Procedure: minimally invasive ablation therapies
4 Recruiting Circulating Tumor Cells and Tumor DNA in HCC and NET
Conditions: Carcinoma, Hepatocellular;   Neuroendocrine Tumors
Interventions: Drug: Sorafenib;   Procedure: Radiofrequency ablation (RFA) or surgery;   Drug: Everolimus;   Drug: Lanreotide
5 Recruiting Laparoscopic Hepatectomy and Radiofrequency Ablation in the Treatment of Early Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Interventions: Procedure: Laparoscopic Hepatectomy;   Procedure: Radiofrequency Ablation
6 Withdrawn The Regression of Liver Fibrosis and Risk for Hepatocellular Carcinoma (ROLFH) Study
Conditions: Chronic Hepatitis C;   Chronic Hepatitis B
Interventions: Other: Regression of fibrosis;   Other: Specific risk factors related to hepatocellular carcinoma
7 Recruiting Transarterial Radioembolization Versus Chemoembolization for the Treatment of Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Interventions: Procedure: Transarterial Radioembolization;   Procedure: Transarterial Chemoembolization using drug-eluting beads

Study has passed its completion date and status has not been verified in more than two years.